Belite Bio BLTE
NASDAQ BLTE
$193.81 +22.72 (+13.28%)
As of: Sep 4, 2026 · 3:59 PM EDT

Belite Bio (BLTE) Property, Plant & Equipment (Net) (2021 - 2025)

Analysis

Belite Bio (BLTE) Property, Plant & Equipment (Net) (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Belite Bio 6.44 Bn 6.44 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 344,000.00
Sep 30, 2025 317,000.00
Dec 31, 2024 444,000.00
Dec 31, 2023 490,000.00
Dec 31, 2022 541,000.00
Dec 31, 2021 94,000.00